| Primary |
| Breast Cancer |
57.2% |
| Hypertension |
11.7% |
| Breast Cancer Metastatic |
5.3% |
| Breast Cancer Female |
4.5% |
| Back Pain |
2.0% |
| Diabetes Mellitus |
2.0% |
| Hypothyroidism |
1.9% |
| Pancreatitis Chronic |
1.8% |
| Pain |
1.7% |
| Insomnia |
1.6% |
| Supplementation Therapy |
1.4% |
| Prophylaxis |
1.3% |
| Arteriosclerosis |
1.2% |
| Depression |
1.2% |
| Angina Pectoris |
1.0% |
| Cataract |
0.9% |
| Gastrooesophageal Reflux Disease |
0.9% |
| Metastasis |
0.9% |
| Osteoporosis |
0.9% |
| Blood Cholesterol Increased |
0.8% |
|
| Pulmonary Embolism |
20.0% |
| Death |
8.2% |
| Cerebrovascular Accident |
7.7% |
| Transient Ischaemic Attack |
5.6% |
| Vomiting |
5.6% |
| Arthralgia |
5.1% |
| Osteopenia |
5.1% |
| Renal Failure |
5.1% |
| Hepatitis Cholestatic |
4.1% |
| Platelet Count Decreased |
3.6% |
| Weight Increased |
3.6% |
| Atrial Fibrillation |
3.1% |
| Cellulitis |
3.1% |
| Deep Vein Thrombosis |
3.1% |
| Diabetes Mellitus |
3.1% |
| Neutrophil Count Decreased |
3.1% |
| Syncope |
3.1% |
| Cataract |
2.6% |
| Disease Progression |
2.6% |
| Febrile Neutropenia |
2.6% |
|
| Secondary |
| Breast Cancer |
41.0% |
| Breast Cancer Metastatic |
25.3% |
| Product Used For Unknown Indication |
7.7% |
| Hypertension |
6.4% |
| Drug Use For Unknown Indication |
2.9% |
| Breast Cancer Female |
2.0% |
| Diabetes Mellitus |
1.9% |
| Metastases To Bone |
1.8% |
| Pain |
1.8% |
| Prophylaxis |
1.7% |
| Depression |
1.0% |
| Hormone Therapy |
1.0% |
| Breast Cancer Stage Iii |
0.8% |
| Hypercholesterolaemia |
0.8% |
| Neoplasm Malignant |
0.8% |
| Chemotherapy |
0.7% |
| Invasive Lobular Breast Carcinoma |
0.7% |
| Constipation |
0.7% |
| Hormone Suppression Therapy |
0.5% |
| Oestrogen Receptor Positive Breast Cancer |
0.5% |
|
| Pulmonary Embolism |
11.8% |
| Vomiting |
10.6% |
| Hyponatraemia |
9.4% |
| Diabetes Mellitus |
6.5% |
| Hepatic Failure |
6.5% |
| Fracture |
5.3% |
| Malignant Neoplasm Progression |
5.3% |
| Rash |
4.1% |
| Diarrhoea |
3.5% |
| Escherichia Infection |
3.5% |
| Pneumonia |
3.5% |
| Pyrexia |
3.5% |
| Sinus Bradycardia |
3.5% |
| Stomatitis |
3.5% |
| Thrombocytopenia |
3.5% |
| Urinary Tract Infection |
3.5% |
| Weight Decreased |
3.5% |
| Febrile Neutropenia |
2.9% |
| General Physical Health Deterioration |
2.9% |
| Osteoporosis |
2.9% |
|
| Concomitant |
| Breast Cancer |
29.4% |
| Breast Cancer Metastatic |
23.2% |
| Product Used For Unknown Indication |
13.6% |
| Metastases To Bone |
6.0% |
| Pain |
5.0% |
| Drug Use For Unknown Indication |
3.8% |
| Hypertension |
3.0% |
| Osteoporosis |
2.9% |
| Constipation |
1.8% |
| Depression |
1.6% |
| Nausea |
1.4% |
| Rheumatoid Arthritis |
1.2% |
| Anaemia |
1.0% |
| Atrial Fibrillation |
1.0% |
| Breast Neoplasm |
1.0% |
| Neoplasm Malignant |
1.0% |
| Fungal Infection |
0.9% |
| Radiotherapy |
0.9% |
| Analgesic Therapy |
0.8% |
| Bone Loss |
0.8% |
|
| Vomiting |
10.9% |
| Weight Decreased |
10.9% |
| Malignant Neoplasm Progression |
8.3% |
| Death |
7.7% |
| Vertigo |
6.4% |
| Stomatitis |
5.1% |
| Tooth Extraction |
5.1% |
| Nausea |
4.5% |
| Metastases To Liver |
3.8% |
| Osteonecrosis |
3.8% |
| Pain In Extremity |
3.8% |
| Thrombocytopenia |
3.8% |
| Tooth Fracture |
3.8% |
| Vaginal Mucosal Blistering |
3.8% |
| Pleural Effusion |
3.2% |
| Pyrexia |
3.2% |
| Syncope |
3.2% |
| Visual Impairment |
3.2% |
| Back Pain |
2.6% |
| Diarrhoea |
2.6% |
|
| Interacting |
| Breast Cancer |
35.6% |
| Product Used For Unknown Indication |
20.3% |
| Metastasis |
15.3% |
| Delirium |
5.1% |
| Bone Pain |
3.4% |
| Hiatus Hernia |
3.4% |
| Hormone Therapy |
3.4% |
| Neoplasm Malignant |
3.4% |
| Arthralgia |
1.7% |
| Breast Cancer Metastatic |
1.7% |
| Hypothyroidism |
1.7% |
| Osteoporosis |
1.7% |
| Pain In Extremity |
1.7% |
| Sedation |
1.7% |
|
| Osteonecrosis |
42.9% |
| Vomiting |
28.6% |
| Drug Interaction |
14.3% |
| Femur Fracture |
14.3% |
|
